Sign in

CIK 0001997038

Iambic Therapeutics, Inc.

Sign in to watch
Ticker
IAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
other
EIN
843364168
Phone
(626) 592-2520
Business address
5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$11,500,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$11,500,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rachlin Evan Lockwood +$11.5M Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2026-10-16 Vogelstein R Jacob Director Conversion +1,995,749 1,995,749
2026-10-16 Vogelstein R Jacob Director Conversion +1,458,290 1,458,290
2026-10-16 Vogelstein R Jacob Director Conversion +742,546 742,546
2026-10-16 Vogelstein R Jacob Director Conversion · Series A Convertible Preferred Stock −1,141,878 0
2026-10-16 Vogelstein R Jacob Director Conversion · Series B Convertible Preferred Stock −731,187 0
2026-10-16 Vogelstein R Jacob Director Conversion · Series B-3 Convertible Preferred Stock −122,684 0
2026-10-16 Vogelstein R Jacob Director Conversion · Series B-4 Convertible Preferred Stock −1,458,290 0
2026-10-16 Vogelstein R Jacob Director Conversion · Convertible Promissory Notes −742,546 0
2026-10-16 Rachlin Evan Lockwood Director Conversion +1,458,736 1,458,736
2026-10-16 Rachlin Evan Lockwood Director Conversion +410,762 1,869,498
2026-10-16 Rachlin Evan Lockwood Director Purchase +718,750 $16.00 $11.5M 2,588,248
2026-10-16 Rachlin Evan Lockwood Director Conversion +57,754 57,754
2026-10-16 Rachlin Evan Lockwood Director Conversion · Series B Convertible Preferred Stock −1,152,025 0
2026-10-16 Rachlin Evan Lockwood Director Conversion · Series B Convertible Preferred Stock −57,754 0
2026-10-16 Rachlin Evan Lockwood Director Conversion · Series B-3 Convertible Preferred Stock −306,711 0
2026-10-16 Rachlin Evan Lockwood Director Conversion · Convertible Promissory Notes −410,762 0
2026-10-16 Catalio Capital Management, LP 10% owner Conversion +1,995,749 1,995,749
2026-10-16 Catalio Capital Management, LP 10% owner Conversion +1,458,290 1,458,290
2026-10-16 Catalio Capital Management, LP 10% owner Conversion +742,546 742,546
2026-10-16 Catalio Capital Management, LP 10% owner Conversion · Series A Convertible Preferred Stock −1,141,878 0

Page 1 of 3 · 49 trades